__________________________________________________________________________________________
Re: Local ID TH140803633 / TH201408009513 FU (1)
Thank you for reporting to us an adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – cramping stomach pain, involving a female patient, 86 Yrs. who was subscribed Forteo, reported the event to Lilly on 25/AUG/2014.
If possible please ask to the attending physician the following questions:
1. Could you please provide reason why she was in hospital first time she took teriparatide?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. Could you please provide stop date of teriparatide treatment?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. Did patient recover of the event after she stopped teriparatide?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: